Differences in pharmacokinetic profiles between long-term kidney/pancreas and non-diabetic kidney transplant patients on tacrolimus and mycophenolate mofetil.

被引：0
|
作者：
Cantarovich, M [1 ]
Paraskevas, S [1 ]
Keith, D [1 ]
Lipman, M [1 ]
Mangel, R [1 ]
Fontaine, G [1 ]
Metrakos, P [1 ]
Tchervenkov, J [1 ]
机构：
[1] McGill Univ, Ctr Hlth, Multi Organ Transplant Program, Montreal, PQ, Canada
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2005年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
687
引用
收藏
页码：331 / 331
页数：1
相关论文
共 50 条
  • [31] Pharmacokinetic/Pharmacodynamic (PK/PD) Monitoring of Mycophenolate Mofetil in De Novo and Long-Term Renal Transplant Patients
    Molinaro, M.
    Chiarelli, L. R.
    Segoloni, G. P.
    Libetta, C.
    Dal Canton, A.
    Regazzi, M.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 665 - 666
  • [32] Lower rate of acute rejection with rapamycin than with mycophenolate mofetil in kidney pancreas transplantation. a randomized, prospective study with thymoglobulin/zenapax induction, tacrolimus and steroid maintenance: Comparing rapamycin with mycophenolate mofetil.
    Burke, GW
    Ciancio, G
    Mattiazzi, A
    Illanes, H
    Gomez, C
    Rosen, A
    Miller, J
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 357 - 357
  • [33] Long-term lipid metabolism in combined kidney-pancreas transplant recipients under tacrolimus immunosuppression
    McCauley, J
    Shapiro, R
    Jordan, ML
    Scantlebury, VP
    Vivas, C
    Jain, A
    Good, D
    Woods, H
    Johnston, J
    Corry, RJ
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1698 - 1699
  • [34] LONG-TERM OUTCOME OF KETOCONAZOLE AND TACROLIMUS CO-ADMINISTRATION IN KIDNEY TRANSPLANT PATIENTS
    LaGuardia, Heather
    Killackey, Mary
    Mills, Katherine
    Kumbala, Damodar
    Khan, Enver
    Paramesh, Anil
    Zhang, Rubin
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (05) : A71 - A71
  • [35] Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil
    Mourad, M
    Malaise, J
    Eddour, DC
    De Meyer, M
    König, J
    Schepers, R
    Squifflet, JP
    Wallemacq, P
    CLINICAL CHEMISTRY, 2001, 47 (01) : 88 - 94
  • [36] THE LONG-TERM OUTCOME OF KETOCONAZOLE AND TACROLIMUS CO-ADMINISTRATION IN KIDNEY TRANSPLANT PATIENTS
    Tulane, Umber A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (02) : 508 - 509
  • [37] Lack of correlation between serum levels of mycophenolate mofetil and kidney transplant outcome in tacrolimus-based immunosupression
    Nanni, G
    Pisanti, F
    Navarra, P
    Boccalini, F
    Citterio, F
    Giustacchini, P
    Preziosi, P
    Castagneto, M
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (06) : 2085 - 2086
  • [38] Pharmacokinetic monitoring of mycophenolate mofetil in de novo kidney-transplant patients receiving belatacept or cyclosporine A
    Kamar, Nassim
    Ribes, David
    Lavit, Michel
    Esposito, Laure
    Lavayssiere, Laurence
    Cointault, Olivier
    Salvin, Sylvie
    Durand, Dominique
    Rostaing, Lionel
    TRANSPLANT INTERNATIONAL, 2007, 20 : 118 - 118
  • [39] Long-Term Outcomes Of Belatacept Versus Tacrolimus In Adult Kidney Transplant
    Newton, Laura
    D'Angelo, Thomas
    Chobanian, Michael
    Daily, Michael
    Zimmerman, Asha
    AMERICAN JOURNAL OF TRANSPLANTATION, 2024, 24 (01) : S78 - S79
  • [40] The Long-Term Outcome of Ketoconazole and Tacrolimus CoAdministration in Kidney Transplant Recipients
    Killackey, M.
    Khan, E.
    Liu, Y.
    Kumbala, D.
    LaGuardia, H.
    Paramesh, A.
    Slakey, D.
    Saggi, B.
    Buell, J.
    Zhang, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 465 - 465
12345